Trial Profile
A Randomized Open-Label Trial of Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Micafungin (Primary) ; Posaconazole (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 04 Apr 2018 Status changed from active, no longer recruiting to completed.
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results assessing effect of micafungin versus posaconazole prophylaxis in patients with acute leukemia or myelodysplastic syndrome, were presented at the IDWeek 2017.